APW
CRDL

Aurora Private Wealth’s Cardiol Therapeutics CRDL Stock Holding History

Aurora Private Wealth’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22K Buy
+21,000
New +$26.6K 0.01% 177

Other funds holding CRDL

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
BFS
Boyer Financial Services Newport Beach, California $118M AUM
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PSB
Piscataqua Savings Bank Portsmouth, New Hampshire $148M AUM 32.61% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Aurora Private Wealth's CRDL Position: Q2 2026 in Review

Aurora Private Wealth opened a new position in Cardiol Therapeutics (CRDL) in Q2 2026: 21,000 shares worth $22K. The stake represents 0.01% of the portfolio and ranks #177 among its holdings.

8 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

  • Aurora Private Wealth held 21,000 shares of Cardiol Therapeutics worth $22K as of Q2 2026.
  • Cardiol Therapeutics was a new Aurora Private Wealth position in Q2 2026.
  • Cardiol Therapeutics made up 0.01% of Aurora Private Wealth's portfolio in Q2 2026, its #177 holding.
  • 8 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on Aurora Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.